Biomarine Technologies, Inc.

Tukwila, WA 98168

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $0.0
First Award Date 01/01/90
Most Recent Award Date 05/01/95

Key Personnel

Last Name Name Awards Contact
Winget Rodner R Winget 8

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/95 - 10/31/95

The long term goal of this research is to develop a new therapy for esophagitis with eicosapentaenoic acid (EPA) compounds extracted from marine algal. EPA has no known side effects other than mild increase in bleeding time when used systemically. Use of marine algal EPA will be a significant contributio...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/21/93 - 08/20/94

The long-term goal of this project is to develop an anti-inflammatory drug, containing eicosapentaenoic acid (EPA) isolated from cultured marine algae, for topical treatment of psoriasis, eczema, and acne. Commercial application is to supply a pharmaceutical firm with bulk product. The phase II portion is to carry development most of the way t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/93 - 10/31/93

The long term goal of this research is to develop topical anti- inflammatory therapy for asthma with eicosapentaenoic acid (EPA) extracted from marine algae. EPA has no known side effects other than a mild increase in bleeding time. This project will develop the technology for purifying a particular fraction from algal extracts containing EPA ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/93 - 11/30/93

The long term goal of this research is to develop topical therapy for cancer with eicosapentaenoic acid (EPA), which has been shown to have anti-inflammatory and anti-tumorigenic properties. EPA has no known side effects other than a mild increase in bleeding time. This project will develop the technology for purifying an EPA-bearing lipid fro...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/21/92 - 08/20/93

The long-term goal of this project is to develop an anti-inflammatory drug, containing eicosapentaenoic acid (EPA) isolated from cultured marine algae, for topical treatment of psoriasis, eczema, and acne. Commercial application is to supply a pharmaceutical firm with bulk product. The phase II portion is to carry development most of the way t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/91 - 10/14/91

DESCRIPTION: (Adapted from Applicant's Abstract) The long term goal of this project is to provide an active ingredient for topical treatment of skin diseases, especially psoriasis, acne, eczema, and atopic dermatitis. The specific aim is to (1) develop the chemistry for isolating a species of polar lipid from marine algae that contain high conc...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/91 - 12/31/91

DESCRIPTION: (Adapted from the applicant's abstract) BioMarine Technologies, Inc. is in the business of developing high value chemicals from cultured microalgae. The products described in this proposal are three forms of eicosapentaenoic acid, an essential fatty acid with therapeutic and prophylactic applications for cardiovascular patients. ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/90 - 12/31/90

DESCRIPTION: (Adapted from the applicant's abstract) BioMarine Technologies, Inc. is in the business of developing high value chemicals from cultured microalgae. The products described in this proposal are three forms of eicosapentaenoic acid, an essential fatty acid with therapeutic and prophylactic applications for cardiovascular patients. ...